Search for Clinical Trial Results
Neisseriaceae Infections - 25 Studies Found
Status | Study |
Completed |
Study Name: Combined Study - Phase 3b MenB Long Term Persistence in Adolescents Condition: Infections, Meningococcal Date: 2015-05-06 Interventions: Biological: Meningococcal Group B (rDNA Component adsorbed) (rMenB+OMV NZ) In Group A, intramuscular Boo |
Active, not recruiting |
Study Name: Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations Condition: Meningococcal Disease Date: 2015-05-13 Interventions: Biological: Menveo® Four Intramuscular doses of MenACWY vaccine at 2, 4, 6 and 12 months of age fol |
Active, not recruiting |
Study Name: Investigating Meningococcal Vaccines in Adults Condition:
|
Active, not recruiting |
Study Name: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study Condition: Meningococcal Disease Date: 2014-10-27 Interventions: Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine This study is strictly observational. D |
Completed |
Study Name: Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents Condition: Meningococcal Disease Date: 2014-11-05 Interventions:
|
Recruiting |
Study Name: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry Condition:
Date: 2014-08-20 Interventions: Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine This pregnancy registry is strictly obs |
Completed |
Study Name: Trial to Assess Immunogenicity and Safety of Novartis Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents Condition: Meningococcal Disease Date: 2014-08-06 Interventions:
|
Completed |
Study Name: Safety and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan. Condition: Meningococcal Disease Date: 2014-06-05 Interventions:
|
Completed |
Study Name: Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. Condition: Meningococcal Disease Date: 2014-05-15 Interventions: Biological: rMenB+OMV 2 doses of vaccine 2 months apart |
Completed |
Study Name: Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents Condition: Meningococcal Disease Date: 2014-05-06 Interventions:
|